New Jersey, April 17, 2023: Freyr, the largest global, Regulatory solutions and services provider, is pleased to announce a new project with a Switzerland-based, leading global specialty chemicals company. The project involves extracting key study data from 3000 study reports in five (05) domains. 

The study reports are distributed across five (05) data categories/endpoints: Human Health Toxicology, Eco-Tox & E-fate, Physical Chemical & Physical Hazard, Substance ID & Analytical, and Efficacy. With a clearly defined process and advanced technology approach supported by manual review, Freyr is all set to extract the data points and deliver high-quality results to the customer. The project focuses on ensuring the customer’s Regulatory team easily accesses the relevant Regulatory information without needing an in-detail review for each study.

“With over a decade of a foothold in the industry, we carry a high-level understanding of chemical development and the data points required for thorough analysis. This win exemplifies Freyr’s strong foothold in the area, and we are sure to match up to the customer’s requirements,” said Mr. Sudheer Goparaju, Vice President of Freyr Solutions.

About Freyr

Freyr Solutions is the largest global, Regulatory solutions and services company that offers end-to-end Regulatory solutions to life sciences industries. The services include Regulatory affairs, pharmacovigilance, clinical research, quality management, and technology solutions such as Regulatory information management systems and Regulatory data integration. Freyr's expertise in Regulatory affairs makes it a trusted partner for life sciences companies seeking to navigate the complex Regulatory landscape.

  • 12+ years in the life sciences Regulatory landscape.
  • 1200+ global customers and growing.
  • 1800+ in-house Regulatory experts.
  • A Global presence across 20+ countries.
  • 950+ in-country Regulatory affiliates across 120+ countries.
  • ISO 9001 & ISO 27001 Certified.